Dubai: AGBL Abyssinia is now fully operational and ready to deliver novel biomedical products and technologies) to the Ethiopian and Northeast African market.

“Ethiopia’s central location, large population and abundant resources, allied to its rich history and stable social policies make it strategically important for AGBL to have presence in this pivotal market”; says Dr. Nassim-Marie Hambouz, Director of commercial operations at AGBL

The AGBL Abyssinia launch event took place at the Addis Ababa Hyatt Regency and was attended by HE Jemal Beker, State Minister for Innovation and Technology, Dr. Kassahun Tesfaye, Director General of the Ethiopian Biotechnology Institute (EBTi), Dr Tamer Degheidy, AGBL Chief Executive Officer, Rodolphe Vetchenou, Illumina Executive Territory Manager, and other dignitaries.

AGBL Keynote speakers addressed corporate overview of the AGBL Group, Next Generation Sequencing solutions and introduced the audience to Illumina's benchtop sequencer; the iSeq 100 system. AGBL also celebrated the establishment of its training Lab at Ethiopian Biotechnology institute (EBTi) and there was an official signing of the MoU between AGBL and EBTi.

About AGBL

AGBL is a member of the Alliance Global Group of companies, the largest biomedical gateway to the emerging markets of the Middle East, Africa, and Asia. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic users in the emerging healthcare markets throughout the regions.

www.agbl.net 

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.